What is Target Screening?
Short answer: Target screening is the process of testing potential acquisition candidates against defined requirements and risks. It turns a broad market universe into a smaller set that merits research, outreach or diligence.
Early screening typically uses public, licensed or otherwise permitted information. It asks whether a company appears to fit the buyer's sector, geography, scale, ownership and strategic needs. Later screening adds management access, financial evidence, conflicts, regulatory feasibility and approachability. Screening differs from due diligence in depth and authority: it identifies credible candidates but cannot confirm facts that remain unavailable. It also differs from a longlist, which records the broad universe, and a shortlist, which represents an approved priority set. Private-investment teams should keep fund mandate, remaining investment period, concentration and follow-on capacity visible alongside commercial fit.
How it works
The team creates an evidence table with one row per target and one column per criterion, including source, date, confidence and owner. Mandatory filters are applied first. Preference scores are then calculated only for survivors, followed by red-flag review for sanctions, conflicts, ownership restrictions, litigation signals or reputational risk. Unknown values are labelled and assigned a next verification step. Decisions to advance, hold or reject are recorded with reasons. Common mistakes include treating estimated revenue as reported revenue, scoring missing information as neutral, allowing different researchers to interpret criteria differently and contacting owners before the buyer has approved confidentiality and competition safeguards.
Screening progression = broad universe - confirmed exclusions - unresolved low-priority candidates = evidence-supported priority set
Example
A buyer maps 75 software providers. Public evidence confirms that 31 serve the wrong customer segment and 14 operate outside the required jurisdictions. Of the remaining 30, ten appear below the scale threshold, but six of those figures are estimates and remain unverified. Ownership research identifies four subsidiaries that cannot be acquired independently and two companies already owned by conflicting sponsors. The team advances eight well-supported candidates, holds six pending revenue verification and rejects the confirmed failures. One candidate with excellent product fit is not scored as compliant until customer concentration data becomes available through an authorised discussion.
Why it matters
Boards use screening evidence to confirm that a proposed acquisition was selected from a reasoned field rather than management preference alone. Corporate-development teams use it to allocate outreach effort. Private-investment teams use it to maintain a traceable pipeline and to test whether sourcing matches the investment mandate. Sellers are not participants in the buyer's early screen, so inclusion never indicates an offer or even contact. A disciplined process makes uncertainty visible and preserves management attention for targets that can actually transact.
Personal data, database licences, confidentiality, market-abuse rules and competition law affect what information can be collected and shared. Automated scores can encode poor assumptions or duplicate entities. Regulatory thresholds and sanctions status change over time, so material facts need current verification. Screening does not establish ownership, financial capacity or willingness to sell. Counsel and specialists should review sensitive outreach, cross-border data and regulated-sector candidates before the process advances.